H pylori eradication: A randomized prospective study of triple therapy with or without ecabet sodium

doi:10.3748/wjg.14.908

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2109)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

227

HTML

1478

Figures (1-1)

216

Tables (1-3)

188

Sum=2109

Feb 14, 2008 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 14, 2008; 14(6): 908-912
Published online Feb 14, 2008. doi: 10.3748/wjg.14.908

Table 2 ITT and PP analysis of H pylori eradication in patients who were randomly assigned to standard triple therapy (group A) or triple therapy plus ecabet sodium (group B)

	Group A	Group B	P value
Eradication rate
ITT¹	72.1% (93/129)	78.9% (101/128)	0.204
PP	78.8% (93/118)	88.6% (101/114)	0.044

¹In this analysis, the patients with unknown outcome were counted as treatment failures.

Citation: Kim HW, Kim GH, Cheong JY, Yang US, Park SK, Song CS, Kang DH, Song GA. H pylori eradication: A randomized prospective study of triple therapy with or without ecabet sodium. World J Gastroenterol 2008; 14(6): 908-912
URL: https://www.wjgnet.com/1007-9327/full/v14/i6/908.htm
DOI: https://dx.doi.org/10.3748/wjg.14.908